Polyclinic Váš Lekár enters clinical trials and significantly strengthens its investment profile
16/01/2026
In recent months, Holding Váš Lekár has focused on streamlining its operations and developing its business, achieving several important milestones that are also significant for the investment opportunity, which you can still join. We will close the investment on January 30, 2026! Express your non-binding interest today.
Business expansion into clinical trials
After lengthy and demanding preparations and negotiations, clinical trials will be conducted at the Váš Lekár polyclinic in cooperation with an international pharmaceutical company. This is a milestone that significantly improves the clinic's profile – it brings a new, high-margin and stable source of income, strengthens the clinic's prestige, and increases its attractiveness to patients and partners alike.
Clinical trials also confirm the professionalism and expertise of the staff and represent an extraordinary success, especially given that the polyclinic has been in existence for less than 2 years. From the second quarter of 2026, clinical trials of drugs for metabolic diseases will begin at the polyclinic. This is the third phase of clinical trials, which means that the drugs being tested have already been proven to meet safety and efficacy criteria.
